Wang Ran, Chen Shuxun, Li Changxian, Ng Kevin Tak Pan, Kong Chi-wing, Cheng Jinping, Cheng Shuk Han, Li Ronald A, Lo Chung Mau, Man Kwan, Sun Dong
Department of Mechanical and Biomedical Engineering, City University of Hong Kong, Hong Kong, China.
Department of Surgery, Li Ka-Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
BMC Cancer. 2016 Feb 4;16:56. doi: 10.1186/s12885-016-2094-7.
Cell fusion is a fast and highly efficient technique for cells to acquire new properties. The fusion of somatic cells with stem cells can reprogram somatic cells to a pluripotent state. Our research on the fusion of stem cells and cancer cells demonstrates that the fused cells can exhibit stemness and cancer cell-like characteristics. Thus, tumor-initiating cell-like cells are generated.
We employed laser-induced single-cell fusion technique to fuse the hepatocellular carcinoma cells and human embryonic stem cells (hESC). Real-time RT-PCR, flow cytometry and in vivo tumorigenicity assay were adopted to identify the gene expression difference.
We successfully produced a fused cell line that coalesces the gene expression information of hepatocellular carcinoma cells and stem cells. Experimental results showed that the fused cells expressed cancer and stemness markers as well as exhibited increased resistance to drug treatment and enhanced tumorigenesis.
Fusion with stem cells transforms liver cancer cells into tumor initiating-like cells. Results indicate that fusion between cancer cell and stem cell may generate tumor initiating-like cells.
细胞融合是一种使细胞获得新特性的快速且高效的技术。体细胞与干细胞的融合可将体细胞重编程为多能状态。我们对干细胞与癌细胞融合的研究表明,融合细胞可表现出干性和癌细胞样特征。因此,产生了肿瘤起始细胞样细胞。
我们采用激光诱导单细胞融合技术将肝癌细胞与人胚胎干细胞(hESC)融合。采用实时逆转录聚合酶链反应(Real-time RT-PCR)、流式细胞术和体内致瘤性试验来鉴定基因表达差异。
我们成功构建了一个融合细胞系,该细胞系整合了肝癌细胞和干细胞的基因表达信息。实验结果表明,融合细胞表达癌症和干性标志物,同时表现出对药物治疗的抗性增加和肿瘤发生增强。
与干细胞融合可将肝癌细胞转化为肿瘤起始样细胞。结果表明癌细胞与干细胞之间的融合可能产生肿瘤起始样细胞。